Ignite Creation Date:
2024-05-06 @ 2:33 AM
Last Modification Date:
2024-10-26 @ 11:20 AM
Study NCT ID:
NCT02068235
Status:
COMPLETED
Last Update Posted:
2015-05-21
First Post:
2014-02-19
Brief Title:
Study to Investigate the Absolute Bioavailability of a Single Oral Dose of Ponesimod in Healthy Male Subjects
Sponsor:
Actelion
Organization:
Actelion
Study Overview
Official Title:
Single-center Open-label Randomized Two-way Crossover Study to Investigate the Absolute Bioavailability of a Single Oral Dose of Ponesimod in Healthy Male Subjects
Status:
COMPLETED
Status Verified Date:
2015-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study consists of a single-dose pilot phase and a randomized two-way crossover single-dose main phaseThe aim of this study is to evaluate the absolute bioavailability of the oral formulation tablet of ponesimod compared to an intravenous iv ponesimod formulation Three subjects will be included in the pilot phase and 12 subjects in the main crossover phase
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None